TC BioPharm Limited Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Employees (Tables)

12 Months Ended

Dec. 31, 2021

	Year ended December 31,		Year ended December 31,		Year ended December 31,
	2021 Number		2020 Number		2019 Number
Number of employees
Average monthly number or persons (including directors) employed by the Group:
Research and development		61		66		83
Management, administration and operations		8		13		11
Number of employees		69		79		94

Management includes employees who are involved in both research and development and administrative operations.

Schedule of staffing costs

	Year ended December 31,		Year ended December 31,		Year ended December 31,
	2021		2020		2019
	£		£		£
Staff costs – included in research and development
Wages and salaries		2,989,066		3,443,726		3,663,845
Social security costs		313,138		386,063		411,114
Pension costs – defined contribution		94,938		130,339		145,223
Share based payments		-		316,259		373,414
Total staff costs		3,397,142		4,276,387		4,593,596
Staff costs – included in administrative expenses
Wages and salaries		877,752		703,366		766,107
Social security costs		56,646		99,040		82,236
Pension costs – defined contribution		42,034		24,548		38,372
Share based payments		-		256,803		462,378
Total staff costs		976,432		1,083,757		1,349,093
Staff costs – combined
Wages and salaries		3,866,818		4,147,091		4,429,952
Social security costs		369,784		485,102		493,350
Pension costs – defined contribution		136,972		154,887		183,595
Share based payments		-		573,062		835,792
Total staff costs		4,373,574		5,360,142		5,942,689

Directors’ remuneration	Year ended December 31,		Year ended December 31,		Year ended December 31,
	2021		2020		2019
	£		£		£
Directors’ remuneration in respect of qualifying services		1,046,324		967,651		676,557
Directors’ employer’s pension contributions		15,001		14,376		12,453
Directors remuneration		1,061,325		982,027		689,010